Trending stocks today
Blue Bird (BLBD-Q)
NASDAQ:BLBD
38.85
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 1 opinions in the last 12 months.
Blue Bird (BLBD-Q) is a specialty school bus maker that also produces alternative fuel buses. With a significant percentage of school buses being over 11 years old, the company has a strong market opportunity for replacements. The recent pullback in the stock price following the US election is seen as a knee-jerk reaction, but the bipartisan support for the company's products provides confidence in its future prospects. Analysts' price target is $56.00, indicating positive sentiment.
$37.660
Owned
- «
- ‹
- 1
- ›
- »
Blue Bird(BLBD-Q) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Blue Bird(BLBD-Q) Frequently Asked Questions
What is Blue Bird stock symbol?
Blue Bird is a American stock, trading under the symbol BLBD-Q on the NASDAQ (BLBD). It is usually referred to as NASDAQ:BLBD or BLBD-Q
Is Blue Bird a buy or a sell?
In the last year, there was no coverage of Blue Bird published on Stockchase.
Is Blue Bird a good investment or a top pick?
Blue Bird was recommended as a Top Pick by on . Read the latest stock experts ratings for Blue Bird.
Why is Blue Bird stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Blue Bird worth watching?
In the last year, there was no coverage of Blue Bird published on Stockchase.
What is Blue Bird stock price?
On 2024-12-24, Blue Bird (BLBD-Q) stock closed at a price of $38.85.
A specialty school bus maker. 47% of school buses are 11 years old or older. An alternative fuel bus maker: propane, hydrogen, electric and gas. Trades at 12x earnings. Things they will make $3 a share next year. The recent pullback is probably a knee-jerk reaction from the Trump election. The issue has bipartisan support however, so not worried about it.
(Analysts’ price target is $56.00)